Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Azitra
Azitra
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Azitra
Stock Price
$0.5
2024-10-29
Market Capitalization
$4 M
2024-10-29
Revenue
$7.5 K
FY, 2024
Azitra Summary
Company Summary
Overview
Azitra is a biotech comapny developing microbiome-based therapeutics to treat skin diseases. The company uses molecular, genetic, and microbiological techniques to be able to address a spectrum of diseases.
Type
Public
Status
Active
Founded
2014
HQ
Branford, CT, US
|
view all locations
Website
https://azitrainc.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
healthtech
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Francisco Salva,
President and CEO
Linkedin
Norman Staskey,
Chief Financial Officer
Locations
View all
1 location detected
Branford, CT
HQ
United States
21 Business Park Dr
Azitra Financials
Summary Financials
Net income (Q1, 2026)
($3.9M)
Cash (Q1, 2026)
$10.1M
Enterprise value
($5.7M)
Competitors and Similar Companies
Transition Bio
Healthcare - Private
Therapeutic Solutions International
Healthcare - Public
Trefoil Therapeutics
Healthcare - Private
Vedanta Biosciences
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top